An award-winning memoir and instant "New York Times" bestseller that goes far beyond its riveting medical mystery, "Brain on Fire" is the powerful account of one woman's struggle to recapture her identity.
When twenty-four-year-old Susannah Cahalan woke up alone in a hospital room, strapped to her bed and unable to move or speak, she had no memory of how she'd gotten there. Days earlier, she had been on the threshold of a new, adult life: at the beginning of her first serious relationship and a promising career at a major New York newspaper. Now she was labeled violent, psychotic, a flight risk. What happened?
In a swift and breathtaking narrative, Susannah tells the astonishing true story of her descent into madness, her family's inspiring faith in her, and the lifesaving diagnosis that nearly didn't happen. "A fascinating look at the disease that . . . could have cost this vibrant, vital young woman her life" ("People"), "Brain on Fire" is an unforgettable exploration of memory and identity, faith and love, and a profoundly compelling tale of survival and perseverance that is destined to become a classic.

When this title was first published in 1971, there were about 300, 000 people with epilepsy in England and Wales. Nearly one-third of them were children. This book is an integrated review of how epileptic children behaved, and of how they were regarded by parents, teachers and peers at the time. Written by a sociologist with a training in psychology, human biology and education, the book draws on several disciplines - sociology, psychology, biology - in seeking to understand the complex determinants of deviant behaviour in children with epilepsy. The author considers in detail the lives of 118 epileptic children, bringing together and analysing a wide range of measurements of behaviour, social relations and abnormalities of brain function. He discusses how the children fare in school, and how epilepsy affects both the teacher's perception of the child and the child's scholastic performance. The dearth of medical centres which could diagnose and treat epilepsy at the time is examined, and hospital use according to parents' social class is analysed. The author looks at the role of parents of epileptic children and shows that their attitude to epilepsy is of major importance for the child's adjustment. The prejudice to which epileptic children and adolescents were subjected by the world at large is chronicled in detail. Finally the author considers how his empirical material makes a contribution to the theoretical problem of integrating sociology, psychology and biology into a single discipline concerned with the explanation of human social behaviour.

Defects in Secretion of Cystic Fibrosis presents an overview on current research from leading experts in North America and Europe. This update on cystic fibrosis provides in depth original work as well as review material on many of the relevant physiological and molecular topics in the field. Subjects covered include the interplay of the various epithelial ion channels, the underlying intracellular signal transduction, mucus secretion, and novel approaches to develop drugs against cystic fibrosis. This book brings together physicians, physiologists, and other scientists involved in basic research, from molecular biology to drug design and introduces novel investigative and therapeutic aspects of secretion disorders relevant in cystic fibrosis and related diseases.

This book will be of interest to Molecular biologists, physiologists, scientists working in pharmaceutical research and drug developement, physicians and researchers in Cystic fibrosis and related diseases.

First published in 1931, this book is the first of three volumes that describe the circumstances of medical work in several European countries at that time. Together, the three books look at public administration, local and national, in relation to the prevention of disease. This first volume focuses on the Dutch, Scandinavian and German speaking countries, as well as Switzerland. It shows that many of these countries have gone beyond most other countries in their in the socialization of medicine in several ways.

First published in 1931, this book is the second of a three volume set which focuses on medical work, and in particular, public administration in relation to the prevention of disease. This volume focuses on the medical circumstances of Belgium, France, Italy, Jugo-Slavia, Hungary, Poland and Czecho-Slovakia. It shows that many of these countries have gone beyond most other countries in their in the socialization of medicine in several ways.

First published in 1931, this book is the third of a three volume set which focuses on medical work, and in particular, public administration in relation to the prevention of disease. This volume provides the most in depth account of the countries it surveys: England and Wales, Scotland, and Ireland.

First published in 1963, Advances in Parasitology contains comprehensive and up-to-date reviews in all areas of interest in contemporary parasitology. Advances in Parasitology includes medical studies of parasites of major influence, such as Plasmodium falciparum and trypanosomes. The series also contains reviews of more traditional areas, such as zoology, taxonomy, and life history, which shape current thinking and applications. The 2012 impact factor is 3.778.

The past few years have witnessed rapid progress in the characterization of mechanisms that underlie the generation and processing of inter- and intracellular signals. While there have been significant corollary advances in the area of signaling in disease processes, there is as yet no single resource that connects these advances with an understanding of disease processes and applications for novel therapeutics. Collecting chapters from the leading experts in their respective fields, editors Toren Finkel and Silvio Gutkind deliver a much-needed introduction to signaling and a fruitful discussion of promising directions for future research.

Signal Transduction and Human Disease capitalizes on the current emphasis on translational research and biological relevance in biotechnology and, conversely, the importance of molecular approaches for clinical research. Each chapter conveys the sense of a disease process, what it affects, how it presents, how common it is, and what the treatments are. Clinical descriptions are not exhaustive but rather serve as an outline regarding the disease’s manifestations and current treatment options. Following this introduction, the authors present an in-depth discussion of one or two signal transduction pathways or biological processes relevant to the disease. The editors divide their study into five sections:

• Cardio-Pulmonary Disease
• Oncology
• Endocrinology
• Infectious Disease
• Allergy/Rheumatology
• Neurology/Psychiatry

Biochemists, molecular and cell biologists, immunologists, pharmacologists, and clinical researchers, as well as graduate students in a variety of scientific disciplines, will find Signal Transduction and Human Disease to be an invaluable addition to the literature.

Volume 109 of "Current Topics in Developmental Biology" covers mouse models of the nuclear envelopathies and related diseases, with contributions from an international board of authors. The chapters provide a comprehensive set of reviews covering such topics as mouse models neurodegenerative diseases including Parkinson s and dystonia, muscle ageing and sarcopenia, cardiac failure and repair, ageing and prospects lifespan extension, lipodystrophy and the significance in fat regulation, also identifying developmental mutations in mammals and nuclear envelope and LINC complex in disease.
Covers the area of mouse models of developmental genetic diseaseInternational board of authors Provides a comprehensive set of reviews covering such topics as mouse models neurodegenerative diseases including Parkinson s, muscle aging, lipodystrophy, and more"

For undergraduates taking introduction courses in communication sciences and disorders. This leading introductory book on communication disorders uses student-friendly content to explore current research, central theories, and the nuts and bolts of clinical therapy. Updated with the most current research and information, the newly revised eighth edition of Human Communication Disorders continues to cover a broad range of topics including speech and language development, genetics, the biology and physics of communication, and an overview of cultural and linguistic diversity. With an emphasis on evidence-based practice, experts in speech-language pathology and audiology place communication processes and communication disorders in perspective, define basic theories of causation, introduce identifying characteristics, and present an overview of procedures for evaluation and treatment - while at the same time focusing on the real people who both have communication disorders and the real people who study them. The new eighth edition has been rewritten with a more contemporary, student-friendly approach and style that makes the content more engaging and easier to process.

An intensive-care doctor reveals the long-term problems caused by ICUs, and how these can be prevented. Thousands of people are admitted to intensive-care units (ICUs) every day, and this is only increasing with the Covid-19 pandemic. Most of these admissions will be sudden, unexpected, and harrowing - an experience that can alter patients and their families in physical, emotional, and spiritual ways, with effects that endure for years. But there is hope. Dr Ely is a leading ICU doctor. His unconventional methods minimise patients being harmed by the cutting-edge technologies that are saving their lives; post-intensive care syndrome (PICS) is a well-established complication that millions of ICU survivors battle, which Dr Ely aims to eradicate. His cutting-edge studies have convinced doctors around the world to change their ICU practices for the better. Through captivating stories, Dr Ely shows how he and colleagues from around the world have re-introduced humanity into the ICU, creating pathways that bring hope and healing to healthcare. This is the future of medicine, and is a must-read for healthcare professionals, patients, and their families.

An account of the use of the gastrointestinal hormone glucagon in different clinical emergencies. An international group of experts from different fields of medicine cover a wide range of situations within acute medicine: cardiology; internal medicine; endocrinology; diabetology; clinical toxicology; surgery; paediatrics; gastroenterology; hepatology; and radiology. Based on an International Workshop held in Barcelona in October 1992, this volume contributes to the growing interest in the importance of glucagon both as a diagnostic tool and as a therapeutic agent in acute medicine. It should be of value to physicians and emergency and critical care specialists as well as to researchers interested in this hormone.

1) Mechanism of Fe(II) Oxidation and Core Formation in Ferritin.- 2) Chemico-Physical and Functional Differences Between H and L Chains of Human Ferritin.- 3) Iron Oxidation in Sheep, Horse and Recombinant Human Apoferritins.- 4) The Transferrin Receptor and the Release of Iron from Transferrin.- 5) The Roles of Secondary Binding Sites for Transferrin in the Liver and on Macrophages.- 6) Optimized Separation and Quantitation of Serum and Cerebrospinal Fluid Transferrin Subfractions Defined by Differences in Iron Saturation or Glycan Composition.- 7) Mechanism of Production of the Serum Transferrin Receptor.- 8) Iron Absorption and Cellular Uptake of Iron.- 9) Ferric Iron Reduction and Iron Uptake in Eucaryotes: Studies with the Yeasts Saccharomyces cerevisiae and Schizosaccharomyces pombe.- 10) Cellular Responses to Iron and Iron Compounds.- 11) The Structure and Function of Iron Regulatory Factor.- 12) Structure and Function of IREs, the Noncoding mRNA Sequences Regulating Synthesis of Ferritin, Transferrin Receptor and (Erythroid) 5-Aminolevulinate Synthase.- 13) Translational Control by Iron-Responsive Elements.- 14) The Role of Cytokines in the Regulation of Ferritin Expression.- 15) Stimulation of IRE-BP Activity of IREF by Tetrahydrobiopterin and Cytokine Dependent Induction of Nitric Oxide Synthase.- 16) Reciprocal Modulation of Aconitase Activity and RNA-binding Activity of Iron Regulatory Factor by Nitric Oxide.- 17) A New Look at Ferritin Metabolism.- 18) Bacterioferritin: A Hemoprotein Member of the Ferritin Family.- 19) Intracellular Iron.- 20) Distinct Features of Iron Metabolism in Erythroid Cells: Implications for Heme Synthesis Regulation.- 21) Cellular Ferritin Uptake: A Highly Regulated Pathway for Iron Assimilation in Human Erythroid Precursor Cells.- 22) Differential Effects of Iron and Iron Carrier on Hematopoietic Cell Differentiation and Human ADA Gene Transfer.- 23) A Hemin-Inducible Enhancer Lies 4. 5 Kb Upstream of the Mouse Ferritin H Subunit Gene.- 24) Iron Deficiency: The Global Perspective.- 25) Iron Regulation in the Brain at the Cell and Molecular Level.- 26) Pathophysiology of Iron Toxicity.- 27) Morphologic Observations in Iron Overload: An Update.- 28) Identification of Thiolic Sarcolemmal Proteins as a Primary Target of Iron Toxicity in Cultured Heart Cells.- 29) Iron Overload and the Biliary Route.- 30) Changing Concepts of Haemochromatosis.- 31) Epidemiology, Clinical Spectrum and Prognosis of Hemochromatosis.- 32) The Morbidity of Hemochromatosis Among Clinically Unselected Homozygotes: Preliminary Report.- 33) Genetics of Haemochromatosis.- 34) Localization of Seven New Genes Around the HLA-A Locus.- 35) Searching for the Hemochromatosis Grail.- 36) Iron Chelator Design.- 37) Results from a Phase I Clinical Trial of HBED.- 38) Lessons from Preclinical and Clinical Studies with 1,2-Diethyl-3-Hydroxypyridin-4-One, CP94 and Related Compounds.- 39) Iron Chelation Therapy for Malaria.- 40) The Biochemical Basis for the Selective Antimalarial Action of Iron Chelators on Plasmodium Falciparum Parasitized Cells.

"Diseases and Diagnoses" discusses why such social problems as addiction, sexually transmitted diseases, racial predisposition for illness, surgery and beauty, and electrotherapy, all of which concerned thinkers a hundred years ago, are reappearing at a staggering rate and in diverse national contexts. In the twentieth century such problems were viewed as only historical concerns. Yet in the twenty-first century, we once again find ourselves confronting their implications.

In this fascinating volume, Gilman looks at historical and contemporary debates about the stigma associated with biologically transmitted diseases. He shows that there is no indisputable way to measure when a disease or therapy will reappear, or how it may be perceived at any given moment in time. Consequently, Gilman focuses on the socio-cultural and political implications that the reappearance of such diseases has had on contemporary society. His approach is to show how culture (embedded in cultural objects) both feeds and is fed by the claims of medical science-as for example, the reappearance of "race" as a cultural as well as a medical category.

If the twentieth century was the "age of physics," in the latter part of the past century and certainly in the twenty-first century biological concerns are recapturing central stage. Achievements of the biological sciences are changing the public's sense of what constitutes cutting-edge science and medicine. None has captured the public imagination more effectively than the mapping of the human genome and the promise of genetic manipulation, which fuel what Gilman calls a "second age of biology." Although not without controversy, the role of genetics appears to be key. Gilman puts contemporary debates in historical context, showing how they feed social and cultural concerns as well as medical possibilities.

Physiology and Metabolism: Genetic Influences on Urinary Calcium Excretion (R.P. Holmes et al.). Oxalate Metabolism and Transport: Vectorial Oxalate Transport across a Monolayer of Renal Epithelial Cells (H. Koul et al.). Physicochemistry, Promoters and Inhibitors: Crystal Growth and Nucleation Rates for Calcium Oxalate in 92% Fresh Urine in a Continuous Crystalliser (J.P. Kavanagh et al.). Crystallization and Proteins: Possible Role of Stone Matrix in Calcium Oxalate Stone Formation (S. Yamaguchi et al.). Stone Composition, Matrix and Membranes: Role of Organic Matrix in Formation and Growth of Calcium Oxalate Urinary Stones (S.R. Khan, R.L. Hackett). Risk Factors and Diet: Urinary Silicate in Calculous Patients (W.C. Thomas). Epidemiology and Infection: Urinary Enzymes (C.H. van Aswegen et al.). ESWL and Lithotropsy: Ultrasound Velocity-A Measure of Stone Strength? (N.P. Cohen et al.). Investigation, Medical and Surgery Management: A New Therapeutic Agent for Cystinuria (T. Koide et al.). 276 additional articles. Index.

Addressing a major field of interest for oncologists, cell biologists, and other biomedical researchers, Beyond Apoptosis provides an overview of how different biological mechanisms of cell death, senescence and mitotic catastrophe stop the growth of tumor cells treated with anticancer agents.

Written by internationally renowned contributors, this text includes:

• morphological illustrations, as well as a DVD containing documents and video clips from various time-lapse microscopic studies of cell death and mitotic catastrophe
• the role and limitations of apoptosis as a determinant of the toxicity of anticancer agents
• alternative mechanisms of the antiproliferative actions of anticancer drugs and radiation, such as non-apoptotic cell death, cell senescence, and mitotic catastrophe
• non-apoptotic forms of cell death, such as necrosis, paraptosis, autophagic cell death, and others
• morphological and kinetic differences of the various forms of cell death

Polio, an infectious disease caused by a virus, became epidemic in the United States in the early to mid-20th century. Recounted in the form of a journal, this story about Edna Black Hindson does a wonderful job making the story of polio come alive. Edna caught polio in 1946, before the height of the epidemic, and the introduction of the vaccine - and well after Franklin Delano Roosevelt turned Warm Springs into the only place focused only on treating poliomyelitis. Thus, her story shows how Americans in the 1940s understood and treated polio, how they were able to use the facilities at Warm Springs and the work it took to help children recover muscle control and the ability to move their limbs that had originally been paralyzed.

Showcasing the expertise of top-tier specialists who contributed to the newly released guidelines for the care of thrombosis in cancer patients, this exciting guide was written and edited by members of the American Society of Clinical Oncology panel, (ASCO), on the prevention and treatment of cancer-associated thrombosis, among others, and provides an authoritative discussion of strategies to effectively implement and interpret the new ASCO/NCCN directives. Standing as the only up-to-date source to readily examine exciting new translational science findings regarding the biology of cancer-associated thrombosis, as well as new clinical recommendations, this guide supplies an authoritative and current discussion of the mechanisms, management, and prevention of cancer-associated thrombosis.

This reference discusses best practices for the management of patients with cancers of the esophagus, stomach, colon, liver, and pancreas. Focusing on a wide variety of GI carcinomas by organ and tumor type, this source provides expert coverage of diagnostic, staging, and treatment procedures by seasoned oncologists and radiologists, and offers in-depth discussions of current research regarding tumor markers, molecular biology, and clinical presentation.

A must for the busy clinician, this source:

• spans the existing evidence from experienced opinion leaders in the field of gastrointestinal oncology
• pairs organ-based chapters so that surgical and non-surgical oncologists provide perspectives on the same condition supplies an up-to-date and relevant summary of the key topics in gastrointestinal oncology, supported by clear scientific evidence
• combines surgical and medical approaches to cancers in specific organs, supplying a rigorous evidence-based approach to the evaluation of various treatments
• addresses critical topics in the area including the management and prevention of cancers around the gastroesophageal junction, rectal cancer, and gastrointestinal stromal tumors
• considers the latest developments in surgical, radiation, and chemotherapeutic management

Following a stellar career as an NFL linebacker, O. J. Brigance joined the Baltimore Ravens' front office. But in 2007, O.J. was diagnosed with amyotrophic lateral sclerosis--also known as Lou Gehrig's disease--and given only three to five years to live. As a player, he'd battled hundreds of setbacks, but none prepared him for this.
With faith and determination in his heart and his wife, Chanda, praying by his side, O.J. fought back against the debilitating disease, even as ALS robbed him of the ability to walk and speak. He kept working, smiling, and touching players' lives all the way to the Ravens' victory at Super Bowl XLVII in 2013--more than five years after his diagnosis.
Now, O.J. shares his incredible story, offering lessons in resilience and reflecting on the team that inspired him in turn. With insights into the Ravens' dynamics from the best seat in the house, O.J. highlights their perseverance, confidence, and leadership, the best that sports can bring out in people.
Full of profound revelations and anecdotes, "Strength of a Champion "is a celebration of the human spirit from a man who left everything on the field.

Patients with mental and substance use disorders have shown higher rates of morbidity and mortality from medical illnesses than the general population, and physicians are also increasingly aware of adverse effects of psychiatric medications on metabolic and cardiovascular health. In light of these problems, this book addresses an important unmet need of patients with mental disorders -- namely, the lack of integration of general medical care with psychiatric care and the related problem of barriers to collaboration and communication among health care providers. Managing Metabolic Abnormalities in the Psychiatrically Ill is the first book to provide a current review of the relationships among psychiatric illnesses, metabolic abnormalities, and treatment, focusing on how clinicians can tailor care to those doubly-afflicted patients.

The book integrates research findings into practical clinical guidelines that spell out what psychiatrists need to know when their patients with mental illness suffer from -- or are at risk of developing -- obesity, diabetes, cardiovascular disease, or the metabolic syndrome. The contributors address those risks that need to be considered in the overall context of treatment, background risks of medical illnesses associated with specific psychiatric disorders themselves, and the means of applying these data to treatment recommendations, monitoring, and clinical practice. Among the specific topics addressed are: - Potential effects of psychotropics on appetite, body weight, and metabolic parameters in obese patients, and the potential effects of anti-obesity agents on psychotic, manic, and depressive syndromes- Increased risk of type 2 diabetes among individuals with psychotic and mood disorders due to neurobiological changes and behavioral effects associated with these disorders- Greater risk for cardiovascular disease among the mentally ill, stressing the importance of mental health providers understanding cardiovascular risk classification and modification strategies- An association between dysregulation of glucose and lipid metabolism and the related risk of type 2 diabetes during treatment with any of the eight second-generation antipsychotics currently available in the United States- Guidance in choice of medications and appropriate monitoring strategies for hyperlipidemia, along with recognition of which antipsychotics pose the greatest risk and an understanding of the common dyslipidemia patterns seen with their use

Chapters include key clinical concepts, quick-reference tables, and extensive references, and a final chapter provides an assessment tool for evaluating patients' metabolic risk. Together, the chapters in this book constitute an authoritative clinical guide that enables psychiatrists to better integrate the treatment of patients' mental disorders with their metabolic conditions.

about the book... Assisting clinicians in the differential diagnosis of the wide range of disorders responsible for fever of unknown origin (FUO), this source stands as the only recent and comprehensive differential diagnosis of these conditions. This guide provides a clear overview of diagnostic approaches and offers expert recommendations that are invaluable to anyone caring for patients with prolonged undiagnosed fever. Written by clinicians for clinicians, this single authoritative source emphasizes the syndromic approach in the diagnosis of FUOs...discusses the etiology and distribution of disorders causing FUOs...and stresses the importance of a focused history, physical examination, and laboratory tests in the differential diagnosis of the FUO patient. about the editor... BURKE A. CUNHA is Chief, Infectious Disease Division, Winthrop-University Hospital, Mineola, New York, and Professor of Medicine, State University of New York School of Medicine, Stony Brook. Dr. Cunha is the author or coauthor of more than 150 abstracts, 100 electronic publications, 1000 articles, and 150 book chapters. He has edited 20 books on various infectious disease topics and is Editor-in-Chief of the journals Infectious Disease Practice and Antibiotics for Clinicians. Dr. Cunha is a Fellow of the Infectious Diseases Society of America. Dr. Cunha is internationally recognized as a teacher-clinician and is the recipient of many teaching awards including the prestigious Aesculapius Award. Dr. Cunha is a Master the American College of Physicians awarded for lifetime achievement as a master clinician and teacher of infectious diseases. Dr. Cunha received the M.D. degree from Pennsylvania State UniversityCollege of Medicine, Hershey.